Journal of Bacteriology, October 1999, p. 6264-6270, Vol. 181, No. 20
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Department of Veterinary and Microbiological Sciences, North Dakota State University, Fargo, North Dakota 58105
Received 29 March 1999/Accepted 26 July 1999
| |
ABSTRACT |
|---|
|
|
|---|
Pseudomonas aeruginosa LasB elastase gene (lasB) transcription is controlled by the two-component quorum-sensing system of LasR, and the autoinducer, 3OC12-HSL (N-3-[oxododecanoyl]homoserine lactone). LasR and 3OC12-HSL-mediated lasB activation requires a functional operator sequence (OP1) in the lasB promoter region. Optimal activation of lasB, however, requires a second sequence of 70% identity to OP1, named OP2, located 43 bp upstream of OP1. In this study, we used sequence substitutions and insertion mutations in lasBp-lacZ fusion plasmids to explore the role of OP2 in lasB activation. Our results demonstrate that (i) OP1 and OP2 synergistically mediate lasB activation; (ii) OP2, like OP1, responds to LasR and 3OC12-HSL; and (iii) the putative autoinducer-binding domain of LasR is not required for synergistic activation from OP1 and OP2.
| |
INTRODUCTION |
|---|
|
|
|---|
Pseudomonas aeruginosa LasB elastase is a well-characterized exoenzyme that contributes to pathogenesis of the organism in animal models (28). Suggestive of its pathogenic potential is its broad substrate range. LasB elastase acts alone or together with other P. aeruginosa proteases to degrade or inactivate several biologically important substrates, including connective tissues and immune system components (29). Detection of lasB transcript in the sputa of cystic fibrosis patients (44) and of antibodies to elastase in cystic fibrosis patients (1, 23) demonstrates that LasB elastase is produced in the human host.
LasB elastase gene (lasB) transcription depends on a cell density-dependent (quorum-sensing) mechanism of gene activation (35). Bacteria with quorum-sensing systems respond to the attainment of a critical culture density by activating transcription of target genes. Quorum sensing as a regulatory mechanism was first described for the marine bacteria Vibrio harveyi and V. fischeri, in which the attainment of a critical mass of bacteria in the symbiotic host's light organ results in expression of the bioluminescence (lux) operon (for a review, see reference 11). Quorum-sensing gene activator complexes are composed of two components: a regulatory protein and an N-acylhomoserine lactone ("autoinducer") molecule. A basal level of autoinducer is constitutively produced and, in the example of V. fischeri, diffuses freely through the cell envelope (22). The intracellular concentration of V. fischeri autoinducer (VAI) is thus dependent upon bacterial cell density. Inside the cell, the autoinducer and regulatory protein form an active complex. The complex recognizes a target gene operator and activates gene transcription (for a review, see reference 11). The first gene of the V. fischeri lux operon codes for autoinducer synthase (luxI). This induction results in a rapid increase in autoinducer concentration that further serves to induce the lux operon, resulting in light emission.
P. aeruginosa quorum-sensing regulatory components are the regulatory protein, LasR, and the autoinducer, 3OC12-HSL (formerly known as PAI-1; N-3-[oxododecanoyl]homoserine lactone) (13, 35, 37). The LasR protein is 30 and 53% identical to V. fischeri regulatory protein (LuxR) at the LuxR autoinducer-binding and DNA-binding domains, respectively (13). The 3OC12-HSL N-acyl side chain is six carbons longer than VAI. Despite structural similarities, the interchangeability of system components in target gene activation is extremely limited (15). In addition, organizational and mechanistic features of the two systems are not identical. In contrast to LuxR and VAI activation of the lux operon, the LasR and 3OC12-HSL complex (LasR/3OC12-HSL) regulated genes are widely separated on the P. aeruginosa chromosome. Two protease genes in addition to lasB are dependent on the presence of LasR/3OC12-HSL: aprA (coding for alkaline protease) and lasA (coding for LasA elastase) (14, 45). Each of these must be independently activated. An additional contrasting feature of the P. aeruginosa system is the active efflux of 3OC12-HSL from the cell, recently reported by Pearson et al. (36), which would limit the intracellular concentration. Thus, cell density and intracellular 3OC12-HSL concentration are not directly proportional in P. aeruginosa.
A sequence upstream of the lasB transcriptional start site,
OP1 (
33 to
52 relative to the transcriptional start site; Fig. 1), is a LasR-responsive operator
(42). OP1 forms an inverted repeat sequence at 18 of 20 bp
and is located immediately upstream of, and may overlap, the
lasB promoter sequence. Mutation of OP1 at various positions
reduced lasB activity by characteristic amounts (42). Expression of lasB in Escherichia
coli was dependent on the presence of LasR and exogenously added
3OC12-HSL, and mutation of OP1 abolished this expression,
indicating that OP1 is a LasR-responsive element.
|
In addition to OP1, a sequence 42 bp upstream of OP1, named OP2 (
94
to
112 relative to the transcriptional start site; Fig. 1), shares
70% identity with OP1. Mutation of OP2 at positions 3 and 5 together
reduced lasB induction by 20% (42). These
results indicate that all or part of the OP2 sequence is involved in
lasB induction.
In this report, we use targeted mutagenesis and sequence replacement to show the extent to which OP2 is involved in lasB induction. We express these mutant lasB upstream regions in the presence or absence of P. aeruginosa regulatory components to show that OP2 is a suboptimal, LasR/3OC12-HSL-responsive sequence. We also show that LasR lacking the putative autoinducer-binding domain elicits synergistic activation from OP1 and OP2, and propose alternative models for OP1- and OP2-mediated lasB activation based on these results.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Strains and culture conditions.
Strains and plasmids used in
this study are listed in Table 1.
P. aeruginosa and E. coli used for genetic
manipulation were cultured in Luria-Bertani (LB) broth or on LB plates
with appropriate antibiotics (100 µg of ampicillin and 30 µg of
chloramphenicol per ml for E. coli; 200 µg of
carbenicillin per ml for P. aeruginosa), at 37°C. P. aeruginosa harboring plasmids and used for
-galactosidase assays was cultured in tryptic soy broth dialysate (TSBD
[33]) with 200 µg of carbenicillin per ml at 37°C,
subcultured into TSBD with carbenicillin, and harvested in early
stationary phase (optical density at 640 nm [OD640] of
~2). E. coli MG4 harboring compatible plasmids for
-galactosidase assays were cultured in modified A medium (A medium
[27] supplemented with 0.1% yeast extract, 0.4%
[vol/vol] glycerol, and 1 mM MgSO4) with appropriate antibiotics at 37°C and subcultured into fresh medium of the same composition. Synthetic 3OC12-HSL was added to the secondary
culture to a final concentration of 100 nM where indicated. Due to the exogenous addition of 3OC12-HSL at the time of subculture,
samples for
-galactosidase assay were taken in mid-logarithmic-phase growth, at an OD600 of ~0.4.
|
Genetic manipulations.
Transformation of E. coli
was carried out by standard methods. Transformation of P. aeruginosa was carried out by the method of Olsen et al.
(34). Sequence substitutions and point mutations were
generated by oligonucleotide-directed mutagenesis and overlap extension
(16). Oligonucleotides used are listed in Table
2. Transcriptional
lasBp-lacZ fusion plasmids were generated as
described previously (42). Briefly, PCR products were
digested with BamHI and HindIII and then
ligated into BamHI/HindIII-digested
pBluescript II KS(+) (Stratagene, La Jolla, Calif.). Inserts were
sequenced for the desired mutation by using a LI-COR automated
sequencer (Lincoln, Nebr.). pBluescript II KS(+) harboring an insert of the desired sequence was digested with BamHI and
HindIII, and the insert was purified from an agarose
gel. The ~224-bp fragments were ligated into
BamHI/HindIII-digested pQF50 to generate
lasBp-lacZ transcriptional fusion plasmids.
|
-Galactosidase assay.
Assays for
-galactosidase
activity were performed according to the method of Miller
(27). Three single-colony isolates of each transformation
were assayed for strain reproducibility. Cultures were assayed in
triplicate, and each experiment was performed at least twice (at least
six determinations). While unit activity from each strain varied
between experiments, relationships between strains were consistent from
experiment to experiment. In addition to unit activity, therefore,
-galactosidase activity levels are also expressed as a range of
activity compared to P. aeruginosa PAO1(pLJR50) (parental
host harboring the wild-type lasB promoter-lacZ transcriptional fusion, 100%; Table 1) to reflect these relationships.
| |
RESULTS |
|---|
|
|
|---|
Effect of OP2 sequence substitutions on lasB
expression.
To investigate the contribution of OP2 to
lasB expression, a series of OP2 sequence replacements was
generated. First, the OP2 sequence (
94 to
112) in pLJR50 was
replaced with a random sequence (pRMA52). The replacement sequence
maintained the G+C content so as to conserve possible secondary
structures (Table 2). In addition, spacing was maintained between OP2
and any upstream P. aeruginosa sequence that may be involved
in regulating lasB expression. Replacement of OP2 resulted
in a 33 to 53% (median, 50%) decline in P. aeruginosa PAO1
lasB expression (Fig. 2),
while mutation of a single critical base pair in OP1, leaving OP2
intact, resulted in a complete absence of lasB expression
(42). Thus, OP1 and OP2 together result in a greater
induction of lasB than the sum of the individual sequences.
|
Effect of insertions on lasB expression.
We sought
to determine whether the contribution of OP2 was dependent on helical
face in relation to OP1 and the promoter sequence. OP1 and OP2 are
separated by 42 bp, or 4.1 turns, and therefore are similarly oriented
with respect to helical face. Either 5 or 10 bp (one half-turn or one
full turn, respectively) were inserted between OP1 and OP2 upstream of
position
68. Surprisingly, insertion of 5 or 10 bp reduced
lasB expression by 21 to 58% (median, 25%) and 82 to 89%,
respectively (Fig. 2). Since the effect of the 10-bp insertion is
greater than that of the random replacement of OP2, these results may
reflect a change in activation from OP1 rather than helical face
independence of OP2 (see Discussion).
Effect of sequence substitutions on transcript formation.
One
of three induction scenarios might account for the synergism seen
between OP1 and OP2. First, the presence of a second, minor OP1-like
operator might allow lasB greater sensitivity to autoinducer
concentration, thus resulting in earlier gene activation. Second, OP2
may allow for a longer induction period over the growth cycle. Finally,
OP1 and OP2 may together increase the rate of transcript formation,
i.e., result in a more efficient promoter. To discriminate between
these possibilities, we cultured P. aeruginosa PAO1(pQF50),
PAO1(pLJR50), PAO1(pRMA52), and PAO1(pRMA2OP1) and assayed for
-galactosidase activity over the course of the growth cycle. Rates
of increase of
-galactosidase activity varied for each of the
lasBp-lacZ fusion plasmids, while time of
induction and duration of induction remained similar (Fig.
3). These results indicate that OP1 and
OP2 increase lasB transcription by increasing the promoter
strength rather than by changing the temporal pattern of gene
induction.
|
OP2-mediated lasB induction in regulatory mutant backgrounds. P. aeruginosa elastase production is dependent on regulatory factors in addition to LasR and 3OC12-HSL. A second system of P. aeruginosa autoinduction has been identified and overlaps in regulating lasB. The complex of RhlR and C4-HSL (formerly known as PAI-2; N-butyrylhomoserine lactone) is required to activate rhamnolipid synthesis (6, 31, 32, 38). A hierarchy of gene activation has been elucidated whereby LasR and 3OC12-HSL partially activate expression of rhlR (RhlR) and rhlI (C4-HSL synthase [24, 39]). In addition to LasR- and 3OC12-HSL-mediated regulation of rhl and lasB, lasB is partially regulated by the rhl system. Mutants of either rhlR or rhlI are deficient not only in rhamnolipid synthesis but also in lasB transcription: rhlI and rhlR backgrounds reduced lasB transcription by 100- and 400-fold, respectively (6). Using pLJR50 (wild-type lasBp-lacZ), we observed decreases of 81 to 96% (median, 87%) and 85 to 88% in rhlI and rhlR backgrounds, respectively (Table 3).
To determine whether a known regulatory protein binds OP2, we assayed lasB promoter activity in various P. aeruginosa regulatory mutant backgrounds. The lasBp-lacZ fusion plasmid pLJR50, pRMA52, pRMA2OP1, pRMA2OP2, or the vector, pQF50, was transformed into strains PDO111 and PDO100 (rhlR and rhlI, respectively), derived from strain PAO1. As in strain PAO1, the OP1 sequence functionally replaced OP2 in each of the rhl strains, although to different extents (Table 3). Likewise, in strain PDO111, expression from pRMA52 was reduced relative to that from pLJR50, a result similar to the pattern of expression in strain PAO1 (Table 3 and Fig. 2). These results indicate that the contribution of RhlR to lasB expression occurs either elsewhere on the lasB regulatory region or indirectly through other regulatory proteins. Interestingly, expression from strain PDO100(pRMA52) was significantly greater than that from strain PDO100(pLJR50) in each experiment. Clearly, the effects of rhlR and rhlI backgrounds on lasB expression are not equivalent.
|
OP2-mediated lasB induction in E. coli in
the presence of LasR and 3OC12-HSL.
We next sought to
determine whether LasR and 3OC12-HSL induce lasB
at OP2 in the absence of other P. aeruginosa factors.
Plasmid pLJR50, pRMA52, pRMA2OP1, or pRMA2OP2 was transformed into
E. coli MG4 in the presence (pPCS11) or absence (pACYC184)
of Ptac-lasR and cultured in the presence or absence of
3OC12-HSL as described in Materials and Methods. As in
P. aeruginosa, OP1 functionally replaced OP2 in the presence
of LasR and 3OC12-HSL (Table
4). In the presence of lasR
and 3OC12-HSL, expression from strains MG4(pRMA52) and
MG4(pRMA2OP2) was induced to 5 and 8%, respectively, that from
strain MG4(pLJR50) (Table 4). These results indicate that LasR and
3OC12-HSL mediate activation from OP2 as well as from OP1
and in the absence of other P. aeruginosa factors.
|
Expression of lasB in the presence of
LasR
aa26-159.
To determine whether synergistic (OP1 and OP2)
activation of the lasB promoter requires full-length LasR, a
PstI fragment internal to lasR was deleted from
pPCS11. This deletion and religation is predicted to code for an
in-frame LasR
aa26-159. This plasmid, pLJR11, was transformed into
E. coli MG4 in combination with each of the pQF50-derived
lasBp-lacZ fusion plasmids pLJR50, pRMA52, and
pRMA2OP1.
-Galactosidase activity was assayed in the presence or
absence of 3OC12-HSL. Expression from strain
MG4(pLJR11)(pLJR50) was reduced to 6%, in the presence or absence of
3OC12-HSL, that from strain MG4(pPCS11)(pLJR50) (Table 4).
This result is consistent with that of K. Tucker's LasR
aa26-159
expression vector and may be due to an N-terminus effect on protein
folding of the DNA binding domain (47). However, due to low
variance, relationships among OP2-substituted promoters expressed in
the presence of the truncated protein could be assessed. Expression
from MG4(pLJR11)(pRMA52) was reduced by 69% from MG4(pLJR11)(pLJR50),
which was restored by substituting OP1 for OP2 (Table 4). These results
indicate that the truncated LasR mediates activation from the upstream operator.
| |
DISCUSSION |
|---|
|
|
|---|
Our results demonstrate that the contribution of OP2 to lasB activation is sequence specific and that OP1 can substitute for OP2 in lasB activation. With the exception of strain PDO100 (rhlI), replacement of OP2 with random sequence resulted in a decrease in lasB expression (Fig. 2 and Tables 3 and 4). In P. aeruginosa PAO1 (parental), PDO100 (rhlI), and PDO111 (rhlR) and in E. coli in the presence of LasR and 3OC12-HSL, OP1 functionally replaced OP2, resulting in expression equal to or greater than the wild-type sequence (Fig. 2 and Tables 3 and 4). The enhanced activity of strain PAO1(pRMA2OP1) was due to an increase in promoter strength rather than to an earlier induction of expression (Fig. 3).
Our results indicate that, like OP1, OP2 is a
LasR/3OC12-HSL-responsive operator. The OP2 operator in the
downstream position mediated a significant level of activation in
E. coli in the presence of LasR and 3OC12-HSL
(Table 4). However, OP2 is not an efficient substitute for OP1, since
the levels of activation from pRMA2OP2 in P. aeruginosa PAO1
and in E. coli in the presence of full-length LasR are 3 and
8%, respectively, that of the nonmutated promoter region (Fig. 2 and
Table 4). Interestingly, Stevens and Greenberg (43) also
identified a sequence upstream of the lux operator protected
by the LuxR DNA-binding domain (LuxR
N). As with lasB OP2,
LuxR
N interaction at this site was not essential for lux operon transcription.
We reported previously that OP1 functions as a
LasR/3OC12-HSL-responsive operator, with its component base
pairs exerting characteristic levels of involvement in lasB
activation (42). These levels of involvement revealed an
asymmetric contribution by each of the operator half-sites, with the
promoter-proximal half-site contributing more to lasB
activation than the promoter-distal half-site. We speculated that LasR
bound to OP1 interacts with RNA polymerase (RNAP) to stabilize the
closed complex and facilitate lasB activation. The position
of OP1, centered at
42.5 and potentially overlapping the
35
promoter determinant, calls to mind that of the 22-bp inverted repeat
CRP galP1 class II promoter operator, which is centered at
41.5 and also overlaps the
35 determinant (5). CRP class
II promoters are characterized by interactions between the RNAP
N-terminal domain (
NTD) and the downstream CRP monomer and between
the RNAP
C-terminal domain (
CTD) and the upstream CRP monomer
(2, 19, 20, 30, 40; for a review, see reference
8). The downstream interaction with
NTD activates
transcription, whereas the upstream interaction with
CTD relieves an
CTD inhibitory effect (49, 50).
In addition to promoter and operator sequences, a third DNA element is
involved in class II promoter activation. RNAP
CTD contacts an
AT-rich sequence upstream of the operator (the UP element
[41]), which is essential for relieving
CTD-mediated inhibition (41). In contrast to the overall
P. aeruginosa mol% GC of 67 (17), the sequence
between OP1 and OP2 is low in G+C content at 25%. Located 4 bp
upstream of OP1 is an AT-rich sequence, 5'-AAATCAA-3' (
63
to
57; Fig. 1). An additional AT-rich sequence of 15 base pairs (
70
to
84; Fig. 1) follows a GC hexamer. One or both of these AT-rich
sequences may function as an UP element for RNAP
CTD binding. Based
on previous results and sequence analyses, LasR-mediated
lasB activation from OP1 may be analogous to CRP class II
promoter activation.
The class II-like model of OP1-mediated activation provides a potential
explanation of the widely disparate levels of activation seen between
the five base pair and the ten base pair insertions (Fig. 2). The
insertions are positioned within the GC hexamer, between the two
AT-rich sequences (Fig. 1). Neither insertion appears to affect the
intrinsic DNA curvature or local bendability (7, 12). Since
the 10-bp insertion resulted in lower activation than random-sequence
replacement of OP2 (Fig. 2), an impact of this insertion on
OP1-mediated activation is probable. The 10-bp insertion may prevent
CTD binding to an OP1-associated UP element, rendering observable
the
CTD inhibitory effect. In addition, the 5-bp insert
(5'-AATTC-3') may increase
CTD-UP element binding affinity,
counteracting any decrease in OP2 contribution. In vitro binding
studies of LasR and RNAP holoenzyme with or without
CTD to the
lasB promoter region will be necessary to distinguish
effects of UP element alteration from effects of operator spacing and helical orientation.
Several alternative roles for OP2 are worthy of consideration. Protein
bound to OP1 and to OP2 may interact in a manner termed pairwise
cooperativity (21). In this model, two dimeric proteins bind
adjacently and cooperatively to DNA, as in
cI binding to OR1 and OR2 to stimulate transcription at
PM (21, 26). However, the length of DNA between
OP1 and OP2 is 4.1 helical turns, or ~140 Å along the axis, while
operator spacing of OR1 and OR2 is a single
helical turn (26). Multiple helical-turn spacing of operators facilitates loop formation, which is characteristic of
promoter repression rather than activation. In addition, the truncated
LasR protein as well as the full-length LasR mediated activation at OP2
(Table 4). Activation at OP2 in the absence of a large portion of the N
terminus, distal to the DNA binding domain, renders pairwise
cooperativity unlikely. However, the moderate and severe reductions in
lasB expression from inserting 5 or 10 bp, respectively,
between OP1 and OP2 suggest other possibilities (Fig. 2). OP2 may
increase the likelihood that LasR will bind to OP1 through
one-dimensional diffusion, which is analogous to the sliding mechanism
of the lac repressor (3). In this model, OP2
provides an expanded target for LasR; insertion of 5 or 10 bp may
reduce the efficiency of LasR tracking to OP1. Alternatively, LasR
interacting with OP2 may induce downstream DNA conformational effects
that contribute to lasB activation, a phenomenon termed allosteric propagation by Vossen et al. (48). Insertion of 5 or 10 bp may interfere with conformational propagation and reduce the
affinity of LasR for OP1. Finally, OP2 may facilitate class I-like
promoter activation. This model is based on CRP dimer-mediated activation of the lac promoter (for a review, see reference
8). In this scenario, OP1 would facilitate class
II-like activation and OP2 would facilitate class I-like activation,
each utilizing an associated UP element. The reality of lasB
activation may be a combination of these models. In vitro binding
studies are underway to discriminate between these possibilities.
Interestingly, the increase in expression from pRMA2OP1 over pLJR50 in P. aeruginosa PAO1 was not reproduced in P. aeruginosa PDO111 (rhlR) or in E. coli MG4(pPCS11) (Tables 3 and 4). While strain PDO111 is isogenic with strain PAO1, the role of RhlR in lasB expression is still unclear, and its absence may be limiting lasB expression at a different level of regulation. Alternatively, the increase in OP1 sequence number may require strain- or species-specific concentrations of active LasR/3OC12-HSL in order to maximize expression. These optimal concentrations may be influenced by plasmid copy number or by intracellular binding conditions. The intracellular concentration of 3OC12-HSL may be a limiting factor in active complex formation, particularly if E. coli has an efflux pump functionally homologous to the proposed P. aeruginosa 3OC12-HSL efflux pump (36). Supporting this hypothesis is the autoinducer-independent overexpression from pRMA2OP1 in the presence of the truncated LasR (Table 4).
The disparate effect of the OP2 random-sequence replacement in the two rhl mutant backgrounds was a surprising result (Table 3). The lack of C4-HSL and the lack of RhlR do not result in equivalent phenotypes, suggesting roles independent of each other. The random sequence in pRMA52 may stimulate lasB transcription in an rhlI background. Alternatively, RhlR may bind OP2 in the absence of C4-HSL, resulting in a nonproductive competition with LasR/3OC12-HSL. Replacement of OP2 would then lead to a relaxation of inhibition in strain PDO100 (rhlI), resulting in unexpectedly high activation from pRMA52. Binding by RhlR to OP2 may result in either a less-stable LasR-RNAP complex that prevents promoter isomerization or from formation of an overly stable LasR-RNAP complex that prevents promoter clearance by the polymerase. Binding by RhlR to OP2 would depend on a number of criteria: (i) RhlR has DNA-binding capability in the absence of its cognate autoinducer, (ii) RhlR recognizes OP2, and (iii) OP2-mediated lasB activation is not a generalized protein-DNA binding effect but rather is specific to LasR binding.
| |
ACKNOWLEDGMENTS |
|---|
We thank the American Lung Association, the North Dakota Agricultural Experiment Station, and North Dakota EPSCoR for supporting this study. Additional support was received through an intramural Grant-in-Aid.
R.M.A. was supported by the American Lung Association Research Grant. We also thank Lou Passador and Barbara H. Iglewski for plasmids and synthetic 3OC12-HSL and Dennis Ohman for use of the P. aeruginosa rhl strains. Finally, we thank Anne Summers, Doug Storey, and Eb Pesci for helpful conversation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Veterinary and Microbiological Sciences, North Dakota State University, Fargo, ND 58105. Phone: (701) 231-7848. Fax: (701) 231-7514. E-mail: lyrust{at}prairie.nodak.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Albus, A., M. Saalmann, H. Tesch, S. S. Pedersen, and G. Doring. 1989. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis. APMIS 97:1146-1148[Medline]. |
| 2. |
Belyaeva, T. A.,
J. A. Bown,
N. Fujita,
A. Ishihama, and S. J. W. Busby.
1996.
Location of the C-terminal domain of the RNA polymerase subunit in different open complexes at the Escherichia coli galactose operon regulatory region.
Nucleic Acids Res.
24:2243-2251.
|
| 3. | Berg, O. G., R. B. Winter, and P. H. von Hippel. 1981. Diffusion-driven mechanisms of protein translocation on nucleic acids. 1. Models and theory. Biochemistry 20:6929-6948[Medline]. |
| 4. |
Bever, R. A., and B. H. Iglewski.
1988.
Molecular characterization and nucleotide sequence of the Pseudomonas aeruginosa elastase structural gene.
J. Bacteriol.
170:4309-4314 |
| 5. | Bingham, A. H., S. Ponnambalam, B. Chan, and S. Busby. 1986. Mutations that reduce expression from the P2 promoter of the Escherichia coli galactose operon. Gene 41:67-74[Medline]. |
| 6. |
Brint, J. M., and D. E. Ohman.
1995.
Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family.
J. Bacteriol.
177:7155-7163 |
| 7. | Brukner, I., R. Sanchez, D. Suck, and S. Pongor. 1995. Sequence dependent bending propensity of DNA as revealed by DNase I: parameters for trinucleotides. EMBO J. 14:1812-1818[Medline]. |
| 8. | Busby, S., and R. H. Ebright. 1997. Transcription activation at class II CAP-dependent promoters. Mol. Microbiol. 23:853-859[Medline]. |
| 9. |
Chang, A. C. Y., and S. N. Cohen.
1978.
Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.
J. Bacteriol.
134:1141-1156 |
| 10. |
Farinha, M. A., and A. M. Kropinski.
1990.
Construction of broad-host-range plasmid vectors for easy visible selection and analysis of promoters.
J. Bacteriol.
172:3496-3499 |
| 11. |
Fuqua, W. C.,
S. C. Winans, and E. P. Greenberg.
1994.
Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators.
J. Bacteriol.
176:269-275 |
| 12. | Gabrielian, A., and S. Pongor. 1996. Correlation of intrinsic DNA curvature with DNA property periodicity. FEBS Lett. 393:65-68[Medline]. |
| 13. |
Gambello, M. J., and B. H. Iglewski.
1991.
Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression.
J. Bacteriol.
173:3000-3009 |
| 14. |
Gambello, M. J.,
S. Kaye, and B. H. Iglewski.
1993.
LasR of Pseudomonas aeruginosa is a transcriptional activator of the alkaline protease gene (apr) and an enhancer of exotoxin A expression.
Infect. Immun.
61:1180-1184 |
| 15. |
Gray, K. M.,
L. Passador,
B. H. Iglewski, and E. P. Greenberg.
1994.
Interchangeability and specificity of components from the quorum-sensing regulatory systems of Vibrio fischeri and Pseudomonas aeruginosa.
J. Bacteriol.
176:3076-3080 |
| 16. | Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1988. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59. |
| 17. | Holloway, B. W., and A. F. Morgan. 1986. Genome organization in Pseudomonas. Annu. Rev. Microbiol. 40:79-105[Medline]. |
| 18. |
Holloway, B. W.,
V. Krishnapillai, and A. F. Morgan.
1979.
Chromosomal genetics of Pseudomonas.
Microbiol. Rev.
43:73-102 |
| 19. |
Igarashi, K.,
A. Hanamura,
K. Makino,
H. Aiba,
T. Mizuno,
A. Nakata, and A. Ishihama.
1991.
Functional map of the alpha subunit of Escherichia coli RNA polymerase: two modes of transcription activation by positive factors.
Proc. Natl. Acad. Sci. USA
88:8958-8962 |
| 20. |
Igarashi, K., and A. Ishihama.
1991.
Bipartite functional map of the E. coli RNA polymerase subunit: involvement of the C-terminal region in transcription activation by cAMP-CRP.
Cell
65:1015-1022[Medline].
|
| 21. |
Johnson, A. D.,
B. J. Meyer, and M. Ptashne.
1979.
Interactions between DNA-bound repressors govern regulation by the phage repressor.
Proc. Natl. Acad. Sci. USA
76:5061-5065 |
| 22. |
Kaplan, H. B., and E. P. Greenberg.
1985.
Diffusion of autoinducer is involved in regulation of the Vibrio fischeri luminescence system.
J. Bacteriol.
163:1210-1214 |
| 23. | Klinger, J. D., D. C. Strauss, C. B. Hilton, and J. A. Bass. 1978. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: demonstration by radioimmunoassay. J. Infect. Dis. 138:49-58[Medline]. |
| 24. | Latifi, A., M. Foglino, K. Tanaka, P. Williams, and A. Lazdunski. 1996. A hierarchical quorum-sensing cascade in Pseudomonas aeruginosa links the transcriptional activators LasR and RhlR to expression of the stationary-phase sigma factor RpoS. Mol. Microbiol. 21:1137-1146[Medline]. |
| 25. | Linn, T., and G. Ralling. 1985. A versatile multiple- and single-copy vector system for the in vitro construction of transcriptional fusions to lacZ. Plasmid 14:134-142[Medline]. |
| 26. | Mao, C., N. G. Carlson, and J. W. Little. 1994. Cooperative DNA-protein interactions. J. Mol. Biol. 235:532-544[Medline]. |
| 27. |
Miller, J.
1972.
Assay of -galactosidase, p. 352-355.
In
Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 28. | Morihara, K., and J. Y. Homma. 1985. Pseudomonas proteases, p. 49-79. In I. A. Holder (ed.), Bacterial enzymes and virulence. CRC Press, Inc., Boca Raton, Fla. |
| 29. | Nicas, T. I., and B. H. Iglewski. 1985. The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Can. J. Microbiol. 31:387-392[Medline]. |
| 30. | Niu, W., Y. Kim, G. Tau, T. Heyduk, and R. H. Ebright. 1996. Transcription activation at class II CAP-dependent promoters: two interactions between CAP and RNA polymerase. Cell 87:1123-1134[Medline]. |
| 31. |
Ochsner, U. A., and J. Reiser.
1995.
Autoinducer-mediated regulation of rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa.
Proc. Natl. Acad. Sci. USA
92:6424-6428 |
| 32. |
Ochsner, U. A.,
A. K. Koch,
A. Fiechter, and J. Reiser.
1994.
Isolation and characterization of a regulatory gene affecting rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa.
J. Bacteriol.
176:2044-2054 |
| 33. |
Ohman, D. E.,
J. C. Sadoff, and B. H. Iglewski.
1980.
Toxin A-deficient mutants of Pseudomonas aeruginosa PA-103: isolation and characterization.
Infect. Immun.
28:899-908 |
| 34. |
Olsen, R. H.,
G. Debusscher, and W. R. McCombie.
1982.
Development of broad-host-range vectors and gene banks: self-cloning of the Pseudomonas aeruginosa PAO chromosome.
J. Bacteriol.
150:60-69 |
| 35. |
Passador, L.,
J. M. Cook,
M. J. Gambello,
L. Rust, and B. H. Iglewski.
1993.
Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication.
Science
260:1127-1130 |
| 36. |
Pearson, J. P.,
C. Van Delden, and B. H. Iglewski.
1999.
Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals.
J. Bacteriol.
181:1203-1210 |
| 37. |
Pearson, J. P.,
K. M. Gray,
L. Passador,
K. D. Tucker,
A. Eberhard,
B. H. Iglewski, and E. P. Greenberg.
1994.
Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes.
Proc. Natl. Acad. Sci. USA
91:197-201 |
| 38. |
Pearson, J. P.,
L. Passador,
B. H. Iglewski, and E. P. Greenberg.
1995.
A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa.
Proc. Natl. Acad. Sci. USA
92:1490-1494 |
| 39. |
Pesci, E. C.,
J. P. Pearson,
P. C. Seed, and B. H. Iglewski.
1997.
Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa.
J. Bacteriol.
179:3127-3132 |
| 40. |
Rhodius, V. A.,
D. M. West,
C. L. Webster,
S. J. W. Busby, and N. J. Savery.
1997.
Transcription activation at class II CRP-dependent promoters: the role of different activating regions.
Nucleic Acids Res.
25:326-332 |
| 41. |
Ross, W.,
K. K. Gosink,
J. Salomon,
K. Igarashi,
C. Zou,
A. Ishihama,
K. Severinov, and R. L. Gourse.
1993.
A third recognition element in bacterial promoters: DNA binding by the subunit of RNA polymerase.
Science
262:1407-1413 |
| 42. |
Rust, L.,
E. C. Pesci, and B. H. Iglewski.
1996.
Analysis of the Pseudomonas aeruginosa elastase (lasB) regulatory region.
J. Bacteriol.
178:1134-1140 |
| 43. |
Stevens, A. M., and E. P. Greenberg.
1997.
Quorum sensing in Vibrio fischeri: essential elements for activation of the luminescence genes.
J. Bacteriol.
179:557-562 |
| 44. |
Storey, D. G.,
E. E. Ujack, and H. R. Rabin.
1992.
Population transcript accumulation of Pseudomonas aeruginosa exotoxin A and elastase in sputa from patients with cystic fibrosis.
Infect. Immun.
60:4687-4694 |
| 45. | Toder, D. S., M. J. Gambello, and B. H. Iglewski. 1991. Pseudomonas aeruginosa LasA: a second elastase under the transcriptional control of lasR. Mol. Microbiol. 5:2003-2010[Medline]. |
| 46. |
Toder, D. S.,
S. J. Ferrell,
J. L. Nezezon,
L. Rust, and B. H. Iglewski.
1994.
lasA and lasB genes of Pseudomonas aeruginosa: analysis of transcription and gene product activity.
Infect. Immun.
62:1320-1327 |
| 47. | Tucker, K. Personal communication. |
| 48. | Vossen, K. M., D. F. Stickle, and M. G. Fried. 1996. The mechanism of CAP-lac repressor binding cooperativity at the E. coli lactose promoter. J. Mol. Biol. 255:44-54[Medline]. |
| 49. | West, D., R. Williams, V. Rhodius, A. Bell, N. Sharma, C. Zou, N. Fujita, A. Ishihama, and S. Busby. 1993. Interactions between the Escherichia coli cyclic AMP receptor protein and RNA polymerase at class II promoters. Mol. Microbiol. 10:789-797[Medline]. |
| 50. | Zhou, Y., P. S. Pendergrast, A. Bell, R. Williams, S. Busby, and R. H. Ebright. 1994. The functional subunit of a dimeric transcription activator protein depends on promoter architecture. EMBO J. 13:4549-4557[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |